The rising interest in GLP-1 agonists for diabetes has led to a question about delivery methods : skin-applied devices versus pills . Usually , GLP-1 therapies were only available in oral form, but the https://deaconwfkk357978.worldblogged.com/47330879/glp-1-transdermal-delivery-systems-vs-tablets-what-suitable-for-individuals